Orakl Oncology is a pioneering precision oncology company founded in 2023 as a spin-off from the Gustave Roussy Institute, focused on accelerating oncology drug development through a first-in-class…
Orakl Oncology is a pioneering precision oncology company founded in 2023 as a spin-off from the Gustave Roussy Institute, focused on accelerating oncology drug development through a first-in-class…
Focus: AI-powered precision oncology platform for drug development
Flagship products: O-Predict; O-Validate
Notable funding: Seed round (Dec 2024); ~€11M–€15M total raised
28 employees
Team size (reported):
Company Overview
Problem Domain
Cancer drug development, with an emphasis on colorectal and pancreatic cancers
Founded
2023
Industry
Biotechnology Research
Funding Track Record
Seed- 2024-12-03
≈€11,000,000
Seed round announced Dec 3, 2024; reporting cites nondilutive support from Bpifrance and total capital raised to date near €15M in some sources.
Investor Signal
“Bpifrance; Singular; additional investors recorded (Amazon Web Services, HCVC, SistaFund, Speedinvest, Verve Ventures)”
Founders
What we do
Join the Team
Senior Scientist
On-Site63 Rue Gabriel Péri, 94270 Le Kremlin-Bicêtre, France, FR
On-Site • 63 Rue Gabriel Péri, 94270 Le Kremlin-Bicêtre, France, FR
We are looking for a passionate and dynamic scientist to build the tools that will fuel Orakl’s drug development efforts. Your role will be to design, build and optimize new screening methods around organoid culture - including our CRISPR strategy. You will drive high-impact discovery efforts by designing and managing the execution of critical in-house experiments, establishing external collaborations with key vendors, and ensuring high-quality, high-velocity data generation.### Must have
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
3,900+
New This Week
Mobile Developer
Full-timeUtrecht, NL
Full-time • Utrecht, NL
Product Designer
Full-timeNew York, US
Full-time • New York, US
Backend Developer
InternshipHamburg, DE
Internship • Hamburg, DE
Product Designer
Part-timeNiš, RS
Part-time • Niš, RS
Backend Developer
Full-timeLondon, GB
Full-time • London, GB
Software Engineer
Full-timeAmsterdam, NL
Full-time • Amsterdam, NL
Related Companies
Company
HQ
Industry
Total Funding
Turbine
🇭🇺Budapest, HU
BiotechnologyDeepTech
$62M
Aignostics
🇩🇪Berlin, DE
BiotechnologyData and AnalyticsDeepTechHealthInformation TechnologySoftware
$55M
Valvian
🇵🇹Lisbon, PT
BiotechnologyDeepTech
-
Elucidata
🇺🇸San Francisco, US
BiotechnologyData and AnalyticsDeepTechHealthInformation TechnologySoftware
$24M
Brenus Pharma
🇫🇷FR
BiotechnologyDeepTechHealth
-
PhD in molecular biology, cancer biology, biotechnology, or related field, ~1–5 years postdoctoral or industry experience would be a plus.
Strong, hands-on expertise in 3D cell culture and patient-derived organoids.
Prior experience in drug screening, and preferably high-throughput screening.
Proven proficiency with CRISPR gene editing in mammalian systems (ideally organoids): gRNA design, engineering, optimization, troubleshooting.
Prior involvement in early-stage drug discovery or cross-functional oncology research.HR Call (15 minutes call) – An initial discussion to better understand your background, experiences, and motivations.
Technical Interview (45 minutes call) – A deep dive into your technical skills and expertise relevant to the role.
Engineering Case (60-minutes presentation + discussion) - You will be presenting a piece of work you have previously worked on and which you are proud of. This will be in front of the relevant members of the Orakl Oncology team. If possible this can be done in person.
Founder Interview: As final step of our recruitment process, you will meet the founders of Orakl Oncology in person at our office. This meeting is an opportunity for the founders to assess cultural fit and ensure alignment with our company values.
